Moo-Seung Lee Selected Research

Histone-Lysine N-Methyltransferase

11/2021

EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moo-Seung Lee Research Topics

Disease

8	Hemolytic-Uremic Syndrome 11/2022 - 04/2013
6	Infections 01/2020 - 12/2013
5	Neoplasms (Cancer) 12/2021 - 01/2016
4	Acute Kidney Injury (Acute Renal Failure) 11/2022 - 01/2010
4	Inflammation (Inflammations) 03/2021 - 04/2013
3	Colitis 11/2022 - 03/2016
2	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2021
2	Human Influenza (Influenza) 01/2022 - 10/2018
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
2	Necrosis 01/2016 - 02/2015
1	Asthma (Bronchial Asthma) 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Leukemia 12/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Diarrhea 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Sepsis (Septicemia) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Typhoid Fever (Typhoid) 01/2018
1	Insulin Resistance 12/2017
1	Obesity 12/2017
1	Blindness (Hysterical Blindness) 10/2017
1	Gout 02/2015
1	Intestinal Diseases (Diseases, Intestinal) 01/2010

Drug/Important Bio-Agent (IBA)

8	Shiga Toxins (Vero Toxin)IBA 11/2022 - 01/2010
7	Virulence Factors (Pathogenicity Factors)IBA 11/2022 - 01/2010
5	CytokinesIBA 11/2020 - 12/2013
4	Shiga Toxin (Shigella Toxin)IBA 09/2018 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2018
3	ChemokinesIBA 01/2020 - 04/2013
2	Biological ProductsIBA 01/2022 - 03/2021
2	ProdigiosinIBA 12/2021 - 03/2021
1	PropionatesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Viral ProteinsIBA 01/2022
1	TrypsinIBA 01/2022
1	InterleukinsIBA 01/2022
1	SmokeIBA 01/2022
1	Ethanol (Ethyl Alcohol)IBA 12/2021
1	Histone-Lysine N-MethyltransferaseIBA 11/2021
1	Histone MethyltransferasesIBA 11/2021
1	src-Family KinasesIBA 01/2021
1	Retinal Pigments (Pigments, Visual)IBA 11/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Ribosome Inactivating ProteinsIBA 01/2020
1	VimentinIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Plant ProteinsIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Lipid AIBA 01/2019
1	LigandsIBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	AntigensIBA 10/2018
1	NucleoproteinsIBA 10/2018
1	Antiviral Agents (Antivirals)IBA 10/2018
1	ginsenoside Rg3IBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	Therapeutic UsesIBA 12/2017
1	NucleotidesIBA 01/2017
1	InflammasomesIBA 02/2015
1	Interleukin-18 (Interleukin 18)IBA 02/2015
1	Interleukin-8 (Interleukin 8)IBA 04/2013
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 04/2013
1	Biomarkers (Surrogate Marker)IBA 04/2013
1	Messenger RNA (mRNA)IBA 04/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2013
1	Drinking WaterIBA 01/2010

Therapy/Procedure

1	Bioreactors (Bioreactor) 12/2021
1	Therapeutics 01/2021
1	Intranasal Administration 01/2020
1	Ligation 01/2019
1	Punctures 01/2019